好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | C229 - Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives

Thursday 05/09/19
03:30 PM - 05:30 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Mario A. Saporta, MD, PhD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should become familiar with the diagnostic work-up, including genetic testing, of inherited peripheral neuropathies and receive an update on new breakthroughs in therapy development in the field.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM EDT Speaker Introduction to Genetic Peripheral Neuropathies
Mario A. Saporta, MD, PhD, FAAN
04:00 PM - 05:00 PM EDT Speaker Molecular Diagnosis of Genetic Neuropathies: Next Generation Sequencing and Beyond
Mario A. Saporta, MD, PhD, FAAN, Stephan Zuchner, MD, FAAN
05:00 PM - 05:30 PM EDT Speaker Therapy Development for Genetic Neuropathies: Current Stage and Perspectives
John Svaren, PhD
Faculty Disclosures
Mario A. Saporta, MD, PhD, FAAN Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
John Svaren, PhD No disclosure on file